Is there a trigger role of peroxynitrite in the anti-arrhythmic effect of ischaemic preconditioning and peroxynitrite infusion?

László Juhász, Attila Kiss, Edit Nyesö, Mária Kovács, György Seprényi, J. Kaszaki, A. Végh

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

This study has examined whether peroxynitrite (PN), generated during the preconditioning (PC) procedure or administered by brief intracoronary infusions, plays a trigger role in the anti-arrhythmic effects of preconditioning and peroxynitrite in anaesthetized dogs. To achieve this we infused the peroxynitrite scavenger uric acid (UA; 0.2 mg/kg/min, i.v.) over a 30 min period, just prior to a 25 min occlusion of the left anterior descending coronary artery, in preconditioned (UA + PC, n = 8), peroxynitrite-treated (UA + PN, n = 8) and in control (UAC; n = 9) dogs. The effects were compared to those obtained from groups (PC, n = 10; PN, n = 10; C1, n = 14) without uric acid administration. Severities of ischaemia (ST-segment elevation, inhomogeneity of electrical activation) and ventricular arrhythmias (VPBs, VT, VF), plasma nitrate/nitrite levels, as well as myocardial superoxide and nitrotyrosine productions were determined. Both preconditioning and the infusion of peroxynitrite increased nitrotyrosine formation which was abolished by the simultaneous administration of urate. Despite this, the protective effects of preconditioning (i.e. reductions in arrhythmias, superoxide and nitrotyrosine productions, as well as the increase in nitric oxide availability), occurring during the prolonged period of occlusion and reperfusion were still present. In contrast, urate completely abolished the protection resulted from peroxynitrite administration. This effect is most probably due to the fact that urate has already scavenged peroxynitrite during the infusion. Interestingly, urate itself, given prior to ischaemia and reperfusion, was also protective. We conclude that peroxynitrite in nanomolar concentrations can induce an anti-arrhythmic effect but peroxynitrite, generated during the preconditioning stimulus, is not necessary for the preconditioning-induced anti-arrhythmic protection.

Original languageEnglish
Pages (from-to)306-313
Number of pages8
JournalEuropean Journal of Pharmacology
Volume667
Issue number1-3
DOIs
Publication statusPublished - Sep 30 2011

Fingerprint

Ischemic Preconditioning
Peroxynitrous Acid
Anti-Arrhythmia Agents
Uric Acid
Superoxides
Reperfusion
Cardiac Arrhythmias
Ischemia
Dogs
Nitrites
Nitrates
Coronary Vessels
Nitric Oxide

Keywords

  • Arrhythmia
  • Ischaemia/reperfusion
  • Peroxynitrite
  • Preconditioning
  • Uric acid

ASJC Scopus subject areas

  • Pharmacology

Cite this

Is there a trigger role of peroxynitrite in the anti-arrhythmic effect of ischaemic preconditioning and peroxynitrite infusion? / Juhász, László; Kiss, Attila; Nyesö, Edit; Kovács, Mária; Seprényi, György; Kaszaki, J.; Végh, A.

In: European Journal of Pharmacology, Vol. 667, No. 1-3, 30.09.2011, p. 306-313.

Research output: Contribution to journalArticle

Juhász, László ; Kiss, Attila ; Nyesö, Edit ; Kovács, Mária ; Seprényi, György ; Kaszaki, J. ; Végh, A. / Is there a trigger role of peroxynitrite in the anti-arrhythmic effect of ischaemic preconditioning and peroxynitrite infusion?. In: European Journal of Pharmacology. 2011 ; Vol. 667, No. 1-3. pp. 306-313.
@article{e3e6eab04ecf49f3a2ee207f956a4ae8,
title = "Is there a trigger role of peroxynitrite in the anti-arrhythmic effect of ischaemic preconditioning and peroxynitrite infusion?",
abstract = "This study has examined whether peroxynitrite (PN), generated during the preconditioning (PC) procedure or administered by brief intracoronary infusions, plays a trigger role in the anti-arrhythmic effects of preconditioning and peroxynitrite in anaesthetized dogs. To achieve this we infused the peroxynitrite scavenger uric acid (UA; 0.2 mg/kg/min, i.v.) over a 30 min period, just prior to a 25 min occlusion of the left anterior descending coronary artery, in preconditioned (UA + PC, n = 8), peroxynitrite-treated (UA + PN, n = 8) and in control (UAC; n = 9) dogs. The effects were compared to those obtained from groups (PC, n = 10; PN, n = 10; C1, n = 14) without uric acid administration. Severities of ischaemia (ST-segment elevation, inhomogeneity of electrical activation) and ventricular arrhythmias (VPBs, VT, VF), plasma nitrate/nitrite levels, as well as myocardial superoxide and nitrotyrosine productions were determined. Both preconditioning and the infusion of peroxynitrite increased nitrotyrosine formation which was abolished by the simultaneous administration of urate. Despite this, the protective effects of preconditioning (i.e. reductions in arrhythmias, superoxide and nitrotyrosine productions, as well as the increase in nitric oxide availability), occurring during the prolonged period of occlusion and reperfusion were still present. In contrast, urate completely abolished the protection resulted from peroxynitrite administration. This effect is most probably due to the fact that urate has already scavenged peroxynitrite during the infusion. Interestingly, urate itself, given prior to ischaemia and reperfusion, was also protective. We conclude that peroxynitrite in nanomolar concentrations can induce an anti-arrhythmic effect but peroxynitrite, generated during the preconditioning stimulus, is not necessary for the preconditioning-induced anti-arrhythmic protection.",
keywords = "Arrhythmia, Ischaemia/reperfusion, Peroxynitrite, Preconditioning, Uric acid",
author = "L{\'a}szl{\'o} Juh{\'a}sz and Attila Kiss and Edit Nyes{\"o} and M{\'a}ria Kov{\'a}cs and Gy{\"o}rgy Sepr{\'e}nyi and J. Kaszaki and A. V{\'e}gh",
year = "2011",
month = "9",
day = "30",
doi = "10.1016/j.ejphar.2011.06.010",
language = "English",
volume = "667",
pages = "306--313",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Is there a trigger role of peroxynitrite in the anti-arrhythmic effect of ischaemic preconditioning and peroxynitrite infusion?

AU - Juhász, László

AU - Kiss, Attila

AU - Nyesö, Edit

AU - Kovács, Mária

AU - Seprényi, György

AU - Kaszaki, J.

AU - Végh, A.

PY - 2011/9/30

Y1 - 2011/9/30

N2 - This study has examined whether peroxynitrite (PN), generated during the preconditioning (PC) procedure or administered by brief intracoronary infusions, plays a trigger role in the anti-arrhythmic effects of preconditioning and peroxynitrite in anaesthetized dogs. To achieve this we infused the peroxynitrite scavenger uric acid (UA; 0.2 mg/kg/min, i.v.) over a 30 min period, just prior to a 25 min occlusion of the left anterior descending coronary artery, in preconditioned (UA + PC, n = 8), peroxynitrite-treated (UA + PN, n = 8) and in control (UAC; n = 9) dogs. The effects were compared to those obtained from groups (PC, n = 10; PN, n = 10; C1, n = 14) without uric acid administration. Severities of ischaemia (ST-segment elevation, inhomogeneity of electrical activation) and ventricular arrhythmias (VPBs, VT, VF), plasma nitrate/nitrite levels, as well as myocardial superoxide and nitrotyrosine productions were determined. Both preconditioning and the infusion of peroxynitrite increased nitrotyrosine formation which was abolished by the simultaneous administration of urate. Despite this, the protective effects of preconditioning (i.e. reductions in arrhythmias, superoxide and nitrotyrosine productions, as well as the increase in nitric oxide availability), occurring during the prolonged period of occlusion and reperfusion were still present. In contrast, urate completely abolished the protection resulted from peroxynitrite administration. This effect is most probably due to the fact that urate has already scavenged peroxynitrite during the infusion. Interestingly, urate itself, given prior to ischaemia and reperfusion, was also protective. We conclude that peroxynitrite in nanomolar concentrations can induce an anti-arrhythmic effect but peroxynitrite, generated during the preconditioning stimulus, is not necessary for the preconditioning-induced anti-arrhythmic protection.

AB - This study has examined whether peroxynitrite (PN), generated during the preconditioning (PC) procedure or administered by brief intracoronary infusions, plays a trigger role in the anti-arrhythmic effects of preconditioning and peroxynitrite in anaesthetized dogs. To achieve this we infused the peroxynitrite scavenger uric acid (UA; 0.2 mg/kg/min, i.v.) over a 30 min period, just prior to a 25 min occlusion of the left anterior descending coronary artery, in preconditioned (UA + PC, n = 8), peroxynitrite-treated (UA + PN, n = 8) and in control (UAC; n = 9) dogs. The effects were compared to those obtained from groups (PC, n = 10; PN, n = 10; C1, n = 14) without uric acid administration. Severities of ischaemia (ST-segment elevation, inhomogeneity of electrical activation) and ventricular arrhythmias (VPBs, VT, VF), plasma nitrate/nitrite levels, as well as myocardial superoxide and nitrotyrosine productions were determined. Both preconditioning and the infusion of peroxynitrite increased nitrotyrosine formation which was abolished by the simultaneous administration of urate. Despite this, the protective effects of preconditioning (i.e. reductions in arrhythmias, superoxide and nitrotyrosine productions, as well as the increase in nitric oxide availability), occurring during the prolonged period of occlusion and reperfusion were still present. In contrast, urate completely abolished the protection resulted from peroxynitrite administration. This effect is most probably due to the fact that urate has already scavenged peroxynitrite during the infusion. Interestingly, urate itself, given prior to ischaemia and reperfusion, was also protective. We conclude that peroxynitrite in nanomolar concentrations can induce an anti-arrhythmic effect but peroxynitrite, generated during the preconditioning stimulus, is not necessary for the preconditioning-induced anti-arrhythmic protection.

KW - Arrhythmia

KW - Ischaemia/reperfusion

KW - Peroxynitrite

KW - Preconditioning

KW - Uric acid

UR - http://www.scopus.com/inward/record.url?scp=80052034249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052034249&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2011.06.010

DO - 10.1016/j.ejphar.2011.06.010

M3 - Article

C2 - 21699894

AN - SCOPUS:80052034249

VL - 667

SP - 306

EP - 313

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -